News Release

Zogenix to Participate in Stifel 2016 Healthcare Conference


EMERYVILLE, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will participate in a fireside chat at the Stifel 2016 Healthcare Conference.

Stifel 2016 Healthcare Conference

Date:   Tuesday, November 15, 2016
Time:   3:45 pm Eastern Time / 12:45 pm Pacific Time
Location:   New York, NY

The presentation will be webcast live and can be accessed on Zogenix's Investor Relations website at

About Zogenix
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

For more information, visit

CONTACT:     Investors: Andrew McDonald
Founding Partner, LifeSci Advisors LLC
646-597-6987 |

Primary Logo

Zogenix, Inc.